Search results
Eli Lilly doubles investment to $2 billion in Concord pharma facility ahead of opening
Charlotte Observer via Yahoo Finance· 12 hours agoEli Lilly has doubled its investment in its new Concord manufacturing facility from $1 billion to $2...
Eli Lilly pharma company debuts new Concord digs with Gov. Cooper on hand
WJZY via Yahoo Finance· 10 hours agoCONCORD, N.C. (QUEEN CITY NEWS) – North Carolina Governor Roy Cooper is in Concord Friday for the...
Pharmaceutical company Eli Lilly opens Concord campus
WSOC via Yahoo News· 5 hours agoA major resource for Concord with hundreds of high-paying jobs has opened its doors. Eli Lilly and...
Poquoson junior Eli Tyndall is the Class 2 Player of the Year, Islanders’ Craig Zimmerman is the...
The Virginian-Pilot· 4 hours agoPoquoson junior Eli Tyndall is the Class 2 Player of the Year, and Islanders’ Craig Zimmerman was...
Optimist Retirement Group LLC Buys New Position in Eli Lilly and Company (NYSE:LLY)
ETF DAILY NEWS· 14 hours agoOptimist Retirement Group LLC bought a new stake in Eli Lilly and Company (NYSE:LLY – Free Report) in the fourth quarter, according to its most recent Form 13F filing with ...
The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune (Revised)
Zacks via Yahoo Finance· 7 hours agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
Oarsman Capital Inc. Increases Stock Position in Eli Lilly and Company (NYSE:LLY)
ETF DAILY NEWS· 12 hours agoOarsman Capital Inc. increased its stake in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 39.5% in the 4th quarter, according to its most recent disclosure with ...
Pharmaceutical company Eli Lilly opens Concord campus
WSOC-TV Charlotte· 5 hours agoA major resource for Concord with hundreds of high-paying jobs has opened its doors. Eli Lilly and...
Gilead Sciences Jumps After Its Weight-Loss Drug Emerges From Under The Radar
Investor's Business Daily· 1 hour agoEvercore ISI analyst Umer Raffat said Gilead Sciences hasn't been hyping the potential rival to Eli...
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 20 hours agoBUSINESS In early 2018, Dave Ricks, the chief executive of the pharmaceutical giant Eli Lilly was on...